Frederick William Jacobs

Title: The Innovations of Frederick William Jacobs

Introduction

Frederick William Jacobs is a notable inventor based in Derbyshire, GB. He has made significant contributions to the field of immunology, particularly with his innovative work on gastrin peptide immunogenic compositions. His research has the potential to impact the treatment of gastrin-dependent diseases.

Latest Patents

Jacobs holds a patent for a gastrin peptide immunogenic composition. This invention provides an immunogenic composition that includes a directed adjuvant comprising an anti-CD32 moiety linked to a TLR9 ligand and a first peptidic alpha-helix. Additionally, it features a gastrin-17 peptide immunogen linked to a second peptidic alpha-helix coiled to the first alpha-helix. The peptide immunogen can be human gastrin-17 or its analogs, with various functional variants. This invention also includes a kit for producing the immunogenic composition and a vaccine for medical use.

Career Highlights

Frederick William Jacobs is associated with Tyg Oncology Ltd., where he continues to advance his research and innovations. His work is crucial in developing new therapeutic approaches for gastrin-dependent diseases.

Collaborations

Jacobs has collaborated with notable colleagues, including Geert Mudde and Paul Christopher Broome. Their combined expertise enhances the research and development of innovative solutions in the field.

Conclusion

Frederick William Jacobs is a distinguished inventor whose work on gastrin peptide immunogenic compositions showcases his commitment to advancing medical science. His contributions have the potential to lead to significant advancements in treating gastrin-dependent diseases.